January 29, 2022

News Science

The Science of News

Hear from first US participant to receive Moderna Phase 3 trial vaccine

1 min read

CNN’s Elizabeth Cohen spoke with Dawn Baker, the first person in the US to get a shot of Moderna’s investigational vaccine in a Phase 3 trial. Moderna is developing it with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

#CNN #News

More News

News Science © 2005 Area.Control.Network™ All rights reserved.
All Rights Reserved © 2020 - 2021 Area Control Network (ACN)
The ACN News websites News.Science use Area Control Network TOS and Privacy Policies that you must agree to to use this site.
Privacy Policies & TOS